Not applicableUnknownNCT04063449What this trial is testingEndostar/PD-1 Inhibitors Combined With PP for Advanced NSCLCWho this might be right forNon-squamous Non-small Cell Lung Cancer Dong Wang 170
Not applicableActive Not RecruitingNCT06504615What this trial is testingObservational Study of Patients Treated With Nivolumab and Chemotherapy for Advanced or Metastatic Esophageal, Gastroesophageal or Gastric Cancer in FranceWho this might be right forGastric AdenocarcinomaGastro-esophageal Junction AdenocarcinomaEsophageal Adenocarcinoma (EAC)+1 more Bristol-Myers Squibb 208
Not applicableStudy completedNCT05677958What this trial is testingProtein Intake in Patients With Colorectal or Lung Cancer When Receiving a Nutritional SupplementWho this might be right forColorectal CancerLung Cancer Nutricia Research 126
Testing effectiveness (Phase 2)Ended earlyNCT04390763What this trial is testingStudy of Efficacy and Safety of NIS793 (With and Without Spartalizumab) in Combination With SOC Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)Who this might be right forMetastatic Pancreatic Ductal Adenocarcinoma Novartis Pharmaceuticals 164
Testing effectiveness (Phase 2)Active Not RecruitingNCT06465563What this trial is testingSHR-8068 in Combination With Adebrelimab, Bevacizumab, and Platinum-Based Chemotherapy as First-line Treatment in Patients With Advanced Biliary Tract CancerWho this might be right forBiliary Tract Cancer Suzhou Suncadia Biopharmaceuticals Co., Ltd. 93
Testing effectiveness (Phase 2)UnknownNCT04262687What this trial is testingChemotherapy and Immunotherapy as Treatment for MSS Metastatic Colorectal Cancer With High Immune InfiltrateWho this might be right forColorectal Cancer MetastaticHigh Immune InfiltrateMicrosatellite Stable Federation Francophone de Cancerologie Digestive 55
Testing effectiveness (Phase 2)UnknownNCT01193452What this trial is testingS-1/Leucovorin (SL) Versus sLV5FU2 as the First-line Treatment for Elderly Patients With Colorectal CancerWho this might be right forColorectal Cancer Fudan University 100
Not applicableActive Not RecruitingNCT04830709What this trial is testingNon-interventional Study to Collect Real-world Clinical and Patient-reported Outcomes in Ovarian CancerWho this might be right forOvarian Cancer AstraZeneca 752
Testing effectiveness (Phase 2)UnknownNCT02000193What this trial is testingMaintenance Hormone Therapy for Postmenopausal HR Positive Advanced Breast CancerWho this might be right forBreast Cancer Sun Yat-sen University 58
Testing effectiveness (Phase 2)Ended earlyNCT01848652What this trial is testingPhase II Study Evaluating a Combination of Pegylated Liposomal Doxorubicin and Dexamethasone for the Treatment of Immunocompetent Patients With Cerebral Lymphoma Relapsed or Refractory to First-line Chemotherapy With High Dose Methotrexate (MTXHD) and / or High-dose Cytarabine.Who this might be right forCerebral Lymphoma B Cell Refractory University Hospital, Brest 5
Testing effectiveness (Phase 2)UnknownNCT02370017What this trial is testingCombined Effect of Natural Killer Cell and Doublet Chemotherapy in Advanced NSCLC as the 1st Line TreatmentWho this might be right forNon-small Cell Lung Cancer The Catholic University of Korea 68
Testing effectiveness (Phase 2)Looking for participantsNCT06177925What this trial is testingA Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLCWho this might be right forRespiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by Site+7 more Nanfang Hospital, Southern Medical University 62
Not applicableActive Not RecruitingNCT05721950What this trial is testingLearn About Brigatinib Treatment Information Available in Chinese Participants With Non-Small-cell Lung Cancer (NSCLC)Who this might be right forNon-small Cell Lung Cancer (NSCLC) Takeda 154
Testing effectiveness (Phase 2)Study completedNCT00423696What this trial is testingBevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryWho this might be right forColorectal Cancer UNICANCER 145
Not applicableUnknownNCT02448576What this trial is testingPCI in Advanced Triple Negative Breast Cancer Patients Who Response to 1st Line ChemotherapyWho this might be right forBreast CancerBrain Metastasis wang shusen 326
Large-scale testing (Phase 3)Looking for participantsNCT06732323What this trial is testingA Phase III Study of ESG401 for Unresectable Recurrent or Metastatic Triple-Negative Breast CancerWho this might be right forTriple-Negative Breast Cancer (TNBC) Qilu Pharmaceutical Co., Ltd. 504
Large-scale testing (Phase 3)UnknownNCT00637325What this trial is testingTrastuzumab Optimization Trial in Breast CancerWho this might be right forMetastatic or Locally Advanced Breast Cancer Regione Lombardia 500
Large-scale testing (Phase 3)Study completedNCT00257608What this trial is testingA Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)Who this might be right forNon-Small Cell Lung Cancer Genentech, Inc. 1,145
Large-scale testing (Phase 3)UnknownNCT03912389What this trial is testingEfficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy as First Line Treatment in Patients With Advanced Non-Squamous NSCLCWho this might be right forNon-Squamous Non-Small Cell Neoplasm of Lung Biocad 292
Large-scale testing (Phase 3)Study completedNCT02625610What this trial is testingAvelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)Who this might be right forUnresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction EMD Serono Research & Development Institute, Inc. 499